I don't know if I can do justice to the question that I wanted to ask Dr. Morgan.
You may have been answering this in response to another colleague's question, but you've mentioned a number of times a national strategy for innovation in R and D with pharmaceuticals.
I'm wondering if you could explain—in about a minute—how you would engage the private sector, entrepreneurs, that group of people, in a national strategy.